EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

PD-L1 Blockade with Biodegradable Envafolimab-Loaded Microspheres Synergizes with Transarterial Chemoembolization to Overcome Myeloid-Derived Suppressor Cell-Driven Immune Escape in Hepatocellular Carcinoma

Hanyuan Liu, Jinxin Huang, Zixuan Wang, Nuofan Wang, Xiaopei Hao, Yue Chai, Na Yu, Hengsong Cao, Yanshu He, Shipeng Dai, Jintao Xu, Zongkang Zhang und 4 weitere

ACS Applied Materials & Interfaces · 28.01.2026 · 18 (3) · 4979-4994

DOI: 10.1021/acsami.5c24260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 18.01.2026. Verfasst von Hanyuan Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, The First Aff…. Hauptthemen laut MEDLINE: Microspheres, Myeloid-Derived Suppressor Cells, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Clinical Subject of Jiangsu Hengrui Pharmaceuticals Co., Ltd, Frontier Projects in Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrospheresMyeloid-Derived Suppressor CellsCarcinoma, HepatocellularLiver NeoplasmsB7-H1 AntigenChemoembolization, TherapeuticAntibodies, Monoclonal, HumanizedAnimalsMiceHumansMice, Inbred BALB CTumor MicroenvironmentCell Line, TumorTumor Escape

Stichwörter der Autor:innen

KN035hepatocellular carcinomamicrospheresmyeloid-derived suppressor cellstransarterial chemoembolization

Substanzen

B7-H1 AntigenAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
  • Center of Interventional Radiology and Vascular Surgery, Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology, Department of Radiology, Zhongda Hospital, Medical School, Sou…
  • State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210029, China.
  • Department of Radiation Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Nanjing 210000, China.
  • Postgraduate College, Nanjing Medical University, Nanjing 210029, China.
  • Department of Hepato-Pancreatico-Biliary Surgery, Zhongda Hospital Southeast University, Nanjing 210009, China.

ORCID-Profile: Fei Xiong, Weiwei Tang

Förderung

  • National Natural Science Foundation of China
  • Clinical Subject of Jiangsu Hengrui Pharmaceuticals Co., Ltd
  • Frontier Projects in Jiangsu Province
  • Henan Provincial Province-Ministry Co-constructed Youth Project
  • Beijing Chen Jumei Foundation
  • Henan Medical Science and Technology Research Program
  • Nanjing Major Science and Technology Project
  • Beijing Guanhe Medical Technology Co., Ltd.

Zitieren

APA

Liu, H., Huang, J., Wang, Z., Wang, N., Hao, X., Chai, Y., Yu, N., Cao, H., He, Y., Dai, S., Xu, J., Zhang, Z., Kong, J., Xiong, F., Tang, W., & Song, J. (2026). PD-L1 Blockade with Biodegradable Envafolimab-Loaded Microspheres Synergizes with Transarterial Chemoembolization to Overcome Myeloid-Derived Suppressor Cell-Driven Immune Escape in Hepatocellular Carcinoma. ACS Applied Materials & Interfaces, 18(3), 4979-4994. https://doi.org/10.1021/acsami.5c24260

Vancouver

Liu H, Huang J, Wang Z, Wang N, Hao X, Chai Y, et al. PD-L1 Blockade with Biodegradable Envafolimab-Loaded Microspheres Synergizes with Transarterial Chemoembolization to Overcome Myeloid-Derived Suppressor Cell-Driven Immune Escape in Hepatocellular Carcinoma. ACS Applied Materials & Interfaces. 2026;18(3):4979-4994. doi:10.1021/acsami.5c24260

BibTeX
@article{Liu2026,
  author = {Liu, Hanyuan and Huang, Jinxin and Wang, Zixuan and Wang, Nuofan and Hao, Xiaopei and Chai, Yue and Yu, Na and Cao, Hengsong and He, Yanshu and Dai, Shipeng and Xu, Jintao and Zhang, Zongkang and Kong, Jie and Xiong, Fei and Tang, Weiwei and Song, Jinhua},
  title = {PD-L1 Blockade with Biodegradable Envafolimab-Loaded Microspheres Synergizes with Transarterial Chemoembolization to Overcome Myeloid-Derived Suppressor Cell-Driven Immune Escape in Hepatocellular Carcinoma},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  volume = {18},
  number = {3},
  pages = {4979--4994},
  doi = {10.1021/acsami.5c24260}
}
Kostenlos starten →